WHO-UMC IDMP Management and Publish API, published by Uppsala Monitoring Centre. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/Uppsala-Monitoring-Centre/WHO-UMC-IDMP-Service/ and changes regularly. See the Directory of published versions
Example AdministrableProductDefinition: AdministrableProductDefinition level 4
Pharmaceutical Product (Administrable Product Definition)
Id | 91B3CA582581F57E4092F13AAF476215 |
Level | 4 |
Ingredients
GSID | Substance name | Strength | GSID9XBS2KCF3K1Z1 | METHOTREXATE SODIUM | 2,74 mg |
Form
Basic dose form | Tablet (BDF-0069) |
Administration method | Swallowing (AME-0019) |
Intended site | Oral (ISI-0031) |
Release characteristics | Conventional (RCA-0047) |
Parent PhPIDs
Level | PhPID | 1 | 93FE88350C2E8868F7E8BD220C4E0010 |
2 | 8195D4AF1287CCE3442C2F308F61DBBC |
3 | 6C4563BB76BE7967594979196EC91CD8 |